199 related articles for article (PubMed ID: 33093907)
1. Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice.
Liu H; Xu S; Li G; Lou D; Fu X; Lu Q; Hao L; Zhang J; Mei J; Sui Z; Lou Y
Exp Ther Med; 2020 Dec; 20(6):170. PubMed ID: 33093907
[TBL] [Abstract][Full Text] [Related]
2. Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice.
Xu J; Pei Z; Yu M; Li X; Wang L; Lin Y; Chen X; Liu X
Biomed Res Int; 2020; 2020():1809326. PubMed ID: 33029491
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK
PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.
Chen J; Li D; Schaefer R; Mehta JL
Atherosclerosis; 2006 Feb; 184(2):295-301. PubMed ID: 16005008
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin protects against endothelial cell apoptosis
Geng J; Xu H; Fu W; Yu X; Xu G; Cao H; Lin G; Sui D
Exp Ther Med; 2020 Jul; 20(1):550-560. PubMed ID: 32537013
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
7. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
8. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
Park KY; Oh E; Kwak MK; Jun HS; Heo TH
PLoS One; 2016; 11(3):e0150791. PubMed ID: 26950217
[TBL] [Abstract][Full Text] [Related]
11. Systematic Investigation of the Effects of Long-Term Administration of a High-Fat Diet on Drug Transporters in the Mouse Liver, Kidney and Intestine.
Lu X; Dong Y; Jian Z; Li Q; Gong L; Tang L; Zhou X; Liu M
Curr Drug Metab; 2019; 20(9):742-755. PubMed ID: 31475894
[TBL] [Abstract][Full Text] [Related]
12. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
Yan J; Li M; Wang XD; Lu ZY; Ni XL
Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
[TBL] [Abstract][Full Text] [Related]
13. Critical role of TNF inhibition in combination therapy for elderly mice with atherosclerosis.
Park KY; Heo TH
Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28643478
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
15. [Protection of huanglian jiedu decoction on systemic and vascular immune responses of high fat induced apoE(-/-) mice].
Ma YL; Wang BB; Han JY; Li R; Zhang WM; Li T; Chen B; Su J; Wang XB; Zeng H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1520-5. PubMed ID: 24483114
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
17. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
19. Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice.
Shin HS; Han JM; Kim HG; Choi MK; Son CG; Yoo HR; Jo HK; Seol IC
J Ethnopharmacol; 2014 Apr; 153(1):142-50. PubMed ID: 24508858
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
